
|Articles|November 1, 2001
How to perform microwave thermotherapy in the office
Benign prostatic hyperplasia afflicts millions of men throughout the world, with an overall prevalence of histologic BPH at autopsy of 50% by age 60 years and 90% by age 85 years (J Urol 1984; 132:474-9). Surgery, although effective, includes a 1% to 3% incidence of mortality.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Sildenafil cream for female sexual arousal disorder available to prescribe in select states
2
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
3
FDA approves ProVee System for benign prostatic hyperplasia
4
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
5















